| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/11/2009 | CN101380333A Method for extracting cellular fluid from human homogeneous variant cell |
| 03/11/2009 | CN101380332A Human homogeneous variant cell extract and use thereof |
| 03/11/2009 | CN101380315A Diphenhydramine filling capsule |
| 03/11/2009 | CN101380103A Dendrobium officinale extracturm and preparation method and use thereof |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467494C Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 03/11/2009 | CN100467488C Il-7 fusion proteins |
| 03/11/2009 | CN100467487C Multifunctional polypeptide |
| 03/11/2009 | CN100467449C Cyclic aminophenyl sulfamate derivative |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives |
| 03/11/2009 | CN100467060C Intratumorally administered lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467059C Use of lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467028C Compound nucleotide oral liquor for improving immunity and its preparing method |
| 03/10/2009 | US7501455 For parental injection of water insoluble drugs such as paclitaxel, propofol, amphotericin B, camptothecin, gemfibrozil and cyclosporin A; plasma protein such as serum albumin, an immunoglobulin, a glycoprotein, an interferon, or an interleukin, in controlled aggregation state |
| 03/10/2009 | US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501399 Immunoeffector compounds |
| 03/10/2009 | US7501274 Lactobacillus pentosus S-PT84 strain; immunomodulators; foods, beverages, drugs |
| 03/10/2009 | US7501260 Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment |
| 03/10/2009 | US7501234 Stress proteins and uses therefor |
| 03/10/2009 | US7501125 Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
| 03/10/2009 | US7501124 Administering allogenic or xenogeneric cell; complexing with antigen |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/10/2009 | CA2352614C Lak activity-screening materials containing lentinus extract of edodes mycelium and lak activity-screening methods using the extract |
| 03/10/2009 | CA2145278C Target binding polypeptide |
| 03/05/2009 | WO2009028411A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 03/05/2009 | WO2009027753A1 Composition and method inhibiting inflammation |
| 03/05/2009 | WO2009027077A2 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 03/05/2009 | WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 03/05/2009 | WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/05/2009 | WO2009012384A3 Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1 |
| 03/05/2009 | WO2009012382A3 Compositions, kits, and methods for the modulation of immune responses using galectin-1 |
| 03/05/2009 | WO2009011889A3 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 03/05/2009 | WO2009010477A8 Piperidine-4-acetic acid derivatives and their use |
| 03/05/2009 | WO2008063776A3 Antibodies to lymphotoxin-alpha |
| 03/05/2009 | US20090062379 Compositions and methods for treating immune disorders |
| 03/05/2009 | US20090062355 Pharmaceutical Product |
| 03/05/2009 | US20090062343 Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 03/05/2009 | US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062305 Deuterium-enriched cetirizine |
| 03/05/2009 | US20090062301 Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one ja k3 kinase inhibitor for treating autoimmune disorders |
| 03/05/2009 | US20090062294 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 03/05/2009 | US20090062289 Immunomodulating oxopyrrazolocinnolines as cd 80 inhibitors |
| 03/05/2009 | US20090062270 Spiro 2,4 pyrimidinediamine compounds and their uses |
| 03/05/2009 | US20090062262 Non steroidal glucocorticoid receptor modulators |
| 03/05/2009 | US20090062249 An intraocular, biodegradable drug delivery system comprising anecortave acetate and a biodegradable glycolic acid-lactic acid copolymer effective in releasing the immunosuppressant into the eye over a period of > 3 weeks; sustained release from a single pellet or a single extruded filament |
| 03/05/2009 | US20090062224 Therapeutic use of cpg oligodeoxynucleotide for skin disease |
| 03/05/2009 | US20090062216 Butanol extract of bidens pilosa |
| 03/05/2009 | US20090062214 Left-Side Glucose Lipid a Analogue |
| 03/05/2009 | US20090062204 Compositions and methods for treating and preventing gastroenteric diseases |
| 03/05/2009 | US20090062198 Maurotoxin, PI1 and HSTX1 derivatives |
| 03/05/2009 | US20090061514 Use of cytokines and mitogens to inhibit graft versus host disease |
| 03/05/2009 | US20090061511 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/05/2009 | US20090060968 Inhibitors of phosphatases |
| 03/05/2009 | US20090060954 Recombinant BCG Vaccine |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria |
| 03/05/2009 | US20090060951 Dna vaccine for koi herpes virus (khv) disease |
| 03/05/2009 | US20090060949 Flu vaccines and methods of use thereof |
| 03/05/2009 | US20090060947 Immunological compositions |
| 03/05/2009 | US20090060946 Activation of antigen-specific T cells by virus/antigen-treated dendritic cells |
| 03/05/2009 | US20090060939 Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides |
| 03/05/2009 | US20090060938 Polyvalent Conjugate Vaccine for Cancer |
| 03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
| 03/05/2009 | US20090060927 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 03/05/2009 | US20090060919 BINDING MEMBERS FOR IgE MOLECULES |
| 03/05/2009 | US20090060918 Method of treating or preventing an IL-1 related disease or condition |
| 03/05/2009 | US20090060911 Enhancement of antibody-mediated immune responses |
| 03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 03/05/2009 | US20090060904 Vegetarian Protein A Preparation and Methods Thereof |
| 03/05/2009 | US20090060902 Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
| 03/05/2009 | US20090060898 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 03/05/2009 | US20090060890 Selective cytopheresis devices and related methods thereof |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | DE102007040615A1 Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen Osmolytes for treating allergic or viral respiratory diseases |
| 03/05/2009 | CA2693707A1 B7-dc variants |
| 03/04/2009 | EP2031056A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 03/04/2009 | EP2030614A1 Pharmaceutical Composition comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol and a lecithin |
| 03/04/2009 | EP2029617A2 N-oxides of kappa opioid receptor peptides |
| 03/04/2009 | EP2029608A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use |
| 03/04/2009 | EP2029597A2 Purine analogs |
| 03/04/2009 | EP2029149A1 Immune privileged and modulatory progenitor cells |
| 03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
| 03/04/2009 | EP2029140A1 Stable and bioavailable formulations and a novel form of desloratadine |
| 03/04/2009 | EP2029132A2 Anti-histamine compositions and use thereof |
| 03/04/2009 | EP2029123A2 Use of a compound with rankl activity |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1418813A4 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1252322B2 Herpes virus strains for gene therapy |
| 03/04/2009 | EP1181366B1 Mammalian receptor proteins; related reagents and methods |
| 03/04/2009 | EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit |
| 03/04/2009 | EP1019085B1 Non-anaphylactic forms of allergens and their use |
| 03/04/2009 | EP0988054B1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |